Page 1 | Search Results | Blood | American Society of Hematology

1-8 of 8

Sort by

Sort Order Select

Journal Articles

Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients

Qian Shi, PhD, Norbert Schmitz, MD, PhD, Christopher Flowers, MD MS, Fang-Shu Ou, PhD, David Cunningham, Michael Pfreundschuh, MD, John F Seymour, Ulrich Jaeger, Thomas M. Habermann, MD, Corinne Haioun, MD PhD, Hervé Tilly, MD PhD, Herve Ghesquieres, MD PhD, Francesco Merli, Marita Ziepert, Raoul Herbrecht, MD, Jocelyne Flament, MD, Tommy Fu, PhD, Bertrand Coiffier, MD PhD, Daniel Sargent, PhD

Blood (2016) 128 (22): 4196.

https://doi.org/10.1182/blood.V128.22.4196.4196

Published: 2016

Journal Articles

Distress and Perceived Impact on Well-Being for Low- or Intermediate-Risk and High-Risk Patients with Chronic Lymphocytic Leukemia (CLL)

Joanne S. Buzaglo, PhD, Melissa F. Miller, PhD MPH, Clare Karten, MS, Elisa S Weiss, PhD, Brian Tomlinson, MPA, BSW, Barbara L Andersen, PhD, Matthew J Matasar, MD MS, John C. Byrd, MD, Christopher Flowers, MD MS

Blood (2016) 128 (22): 5970.

https://doi.org/10.1182/blood.V128.22.5970.5970

Published: 2016

Journal Articles

An Evaluation of the Role of Surveillance Imaging in Mantle Cell Lymphoma in First Remission

Daniel M Guidot, MPH, Jeffrey Switchenko, PhD, Loretta J. Nastoupil, MD, Jean L. Koff, MD, Christopher Flowers, MD MS, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 1799.

https://doi.org/10.1182/blood.V128.22.1799.1799

Published: 2016

Journal Articles

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Kami J. Maddocks, MD, Jonathon B. Cohen, MD, Ying Huang, MA, MS, Beth A Christian, MD, Don M Benson, MD PhD, Jeffrey Jones, MD MPH, Christopher Flowers, MD MS, Leonard T. Heffner, MD, Cynthia Jenkins, RN, Jennfer Sexton, MHA, CCRC, Alison Neal, MPH, Melissa Kives, MPH, Kristie A. Blum, MD

Blood (2016) 128 (22): 1776.

https://doi.org/10.1182/blood.V128.22.1776.1776

Published: 2016

Journal Articles

Risk Stratification of Untreated Mantle Cell Lymphoma Patients Using MIPI, Ki67 Proliferative Index and Cytogenetics

Ashley D. Staton, MD, Irl Brian Greenwell, MD, Jeffrey M Switchenko, Joseph Maly, MD, Kristie Blum, MD, Natalie S. Grover, MD, Stephanie Mathews, Steven I. Park, MD, Max J. Gordon, MD, Alexey V Danilov, MD PhD, Narendranath Epperla, MD, Timothy S Fenkse, MD MS, Mehdi Hamadani, MD, Christopher Flowers, MD MS, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 1785.

https://doi.org/10.1182/blood.V128.22.1785.1785

Published: 2016

Journal Articles

Assessing the Feasibility of Pathology Informatics Approaches for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)

Serina J Lewis, Jordan Goldstein, Monique Farone, MPH, Anh Thuy Phan, MPH, Jean L. Koff, MD, Ashley D. Staton, MD, Pooya Mobadersany, Lee Cooper, PhD, Christopher Flowers, MD MS

Blood (2016) 128 (22): 5408.

https://doi.org/10.1182/blood.V128.22.5408.5408

Published: 2016

Journal Articles

Use of Metabolic Tumor Volume (MTV) in Patients with Mantle Cell Lymphoma

Daniel M Guidot, MPH, Ila Sethi, MD, Jeffrey Switchenko, PhD, Daniel Lee, MD, Loretta J. Nastoupil, MD, Jean L. Koff, MD, Christopher Flowers, MD MS, Jonathon B. Cohen, MD

Blood (2016) 128 (22): 5321.

https://doi.org/10.1182/blood.V128.22.5321.5321

Published: 2016

Journal Articles

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Amelia A. Langston, MD, Leonard T. Heffner, MD, Donald Hutcherson, RPh, Jessica Neely, MS, Christopher Flowers, MD, MS, Edmund K. Waller, MD, PhD, Sagar Lonial, MD, Hanna J. Khoury, MD, Elliot Winton, MD

Blood (2005) 106 (11): 4634.

https://doi.org/10.1182/blood.V106.11.4634.4634

Published: 2005

NARROW

Evaluation of Progression-Free Survival (PFS) As a Surrogate Endpoint for Overall Survival (OS) in First-Line Therapy for Diffuse Large B-Cell Lymphoma (DLBCL): Findings from the Surrogate Endpoint in Aggressive Lymphoma (SEAL) Analysis of Individual Patient Data from 7507 Patients

Distress and Perceived Impact on Well-Being for Low- or Intermediate-Risk and High-Risk Patients with Chronic Lymphocytic Leukemia (CLL)

An Evaluation of the Role of Surveillance Imaging in Mantle Cell Lymphoma in First Remission

a Phase I Study of BKM120 (Buparlisib) and Rituximab in Patients with Relapsed or Refractory (R/R) B-Cell Non-Hodgkin's Lymphoma (NHL)

Risk Stratification of Untreated Mantle Cell Lymphoma Patients Using MIPI, Ki67 Proliferative Index and Cytogenetics

Assessing the Feasibility of Pathology Informatics Approaches for Subtyping Diffuse Large B-Cell Lymphoma (DLBCL)

Use of Metabolic Tumor Volume (MTV) in Patients with Mantle Cell Lymphoma

Relapse Free Survival of Elderly AML Patients Is Comparable to That of Younger Adults When Treated with a Modified Dose Intensive Cytarabine Regimen.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only